Detalhe da pesquisa
1.
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma.
Blood
; 117(17): 4542-51, 2011 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21300981
2.
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors.
Mol Cancer Ther
; 21(7): 1047-1059, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511740
3.
Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties.
Breast Cancer Res
; 13(6): R123, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22129105
4.
Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold.
Arthritis Rheum
; 62(7): 1933-43, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20506263
5.
Multispecific, Multivalent Antibody-Based Molecules Engineered on the DART® and TRIDENTTM Platforms.
Curr Protoc Immunol
; 129(1): e95, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294319
6.
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer.
Mol Cancer Ther
; 19(11): 2235-2244, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967924
7.
Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer.
Mol Cancer Ther
; 17(8): 1761-1772, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866746
8.
A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: preclinical activity and safety in nonhuman primates.
Sci Transl Med
; 7(289): 289ra82, 2015 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26019218
9.
Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity.
Clin Cancer Res
; 18(14): 3834-45, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22615450
10.
Effector cell recruitment with novel Fv-based dual-affinity re-targeting protein leads to potent tumor cytolysis and in vivo B-cell depletion.
J Mol Biol
; 399(3): 436-49, 2010 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-20382161
11.
Transfection of cultured eukaryotic cells using cationic lipid reagents.
Curr Protoc Mol Biol
; Chapter 9: Unit 9.4, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18231984
12.
Optimization of tetracycline-responsive recombinant protein production and effect on cell growth and ER stress in mammalian cells.
Biotechnol Bioeng
; 91(6): 722-32, 2005 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15981277
13.
Transfection of cultured eukaryotic cells using cationic lipid reagents.
Curr Protoc Cell Biol
; Chapter 20: Unit 20.6, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18228430
14.
Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications.
Methods
; 33(2): 95-103, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15121163